John Climaco
2020
In 2020, John Climaco earned a total compensation of $1.6M as Chairman and Chief Executive Officer at CNS Pharmaceuticals, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,100 |
|---|---|
| Option Awards | $937,808 |
| Salary | $440,000 |
| Total | $1,572,908 |
Climaco received $937.8K in option awards, accounting for 60% of the total pay in 2020.
Climaco also received $195.1K in non-equity incentive plan and $440K in salary.
Rankings
In 2020, John Climaco's compensation ranked 6,632nd out of 13,090 executives tracked by ExecPay. In other words, Climaco earned more than 49.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,632 out of 13,090 | 49th |
Division Manufacturing | 2,753 out of 5,617 | 51st |
Major group Chemicals And Allied Products | 1,110 out of 2,248 | 51st |
Industry group Drugs | 960 out of 1,948 | 51st |
Industry Pharmaceutical Preparations | 719 out of 1,453 | 51st |
Source: SEC filing on June 7, 2021.
Climaco's colleagues
We found two more compensation records of executives who worked with John Climaco at CNS Pharmaceuticals in 2020.